Overproduction of hydrogen sulfide, generated by cystathionine β-synthase, disrupts brain wave patterns and contributes to neurobehavioral dysfunction in a rat model of down syndrome
Theodora Panagaki,
Laura Lozano-Montes,
Lucia Janickova,
Karim Zuhra,
Marcell P. Szabo,
Tomas Majtan,
Gregor Rainer,
Damien Maréchal,
Yann Herault,
Csaba Szabo
Affiliations
Theodora Panagaki
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Laura Lozano-Montes
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Visual Cognition Laboratory, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Lucia Janickova
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Karim Zuhra
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Marcell P. Szabo
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Tomas Majtan
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Gregor Rainer
Visual Cognition Laboratory, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
Damien Maréchal
Université de Strasbourg, CNRS, INSERM, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
Yann Herault
Université de Strasbourg, CNRS, INSERM, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France
Csaba Szabo
Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland; Corresponding author. Chair of Pharmacology, Faculty of Science and Medicine, University of Fribourg, Chemin du Musée 18, Fribourg, 1700, Switzerland.
Using a novel rat model of Down syndrome (DS), the functional role of the cystathionine-β-synthase (CBS)/hydrogen sulfide (H2S) pathway was investigated on the pathogenesis of brain wave pattern alterations and neurobehavioral dysfunction. Increased expression of CBS and subsequent overproduction of H2S was observed in the brain of DS rats, with CBS primarily localizing to astrocytes and the vasculature. DS rats exhibited neurobehavioral defects, accompanied by a loss of gamma brain wave activity and a suppression of the expression of multiple pre- and postsynaptic proteins. Aminooxyacetate, a prototypical pharmacological inhibitor of CBS, increased the ability of the DS brain tissue to generate ATP in vitro and reversed the electrophysiological and neurobehavioral alterations in vivo. Thus, the CBS/H2S pathway contributes to the pathogenesis of neurological dysfunction in DS, most likely through dysregulation of cellular bioenergetics and gene expression.